suppressor cells
A dynamic metabolic flux analysis of myeloid-derived suppressor cells confirms immunosuppression-related metabolic plasticity
15
Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in septic patients
57
Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
17
Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow
40
Deciphering myeloid-derived suppressor cells isolation and markers in humans, mice and non-human primates
12
Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models
16
Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets
13
en fr Myeloid-derived suppressor cells in septic patients Cellules suppressives d'origine myéloïde au cours du sepsis
279
HIF-1α is a key regulator in potentiating suppressor activity and limiting the microbicidal capacity of MDSC-like cells during visceral leishmaniasis
27
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB
11
FGFR3 has tumor suppressor properties in cells with epithelial phenotype.
14
Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
7
Tumor suppressor fumarate hydratase is phosphorylated and regulated by AMP-activated protein kinase
3
Magi1, a new potential tumor suppressor gene in estrogen receptor positive breast cancer
23
Downregulation of putative tumor suppressor gene TSC-22 in human brain tumors.
8
The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition
15
VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX
17
Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.
3
The transcriptional activator $HAP4$ is a high copy suppressor of an $oxa1$ yeast mutation
6
MODELLING NUCLEOCYTOPLASMIC TRANSPORT WITH APPLICATION TO THE INTRACELLULAR DYNAMICS OF THE TUMOR SUPPRESSOR PROTEIN P53
166